Jaykaran Charan
- Infectious Diseases top 2%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 5%
- Epidemiology top 5%
- Surgery top 10%
- Co-authors
- Tamoghna BiswasN. D. KanthariaRimple Jeet KaurDeepak SaxenaPankaj BhardwajJagdish Prasad GoyalSiddhartha DuttaMainul Haque
- Topics
- COVID-19 Clinical Research Studies (18 papers)SARS-CoV-2 and COVID-19 Research (12 papers)Pharmaceutical Economics and Policy (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONECochrane Database of Systematic Reviews
- Partner nations
- IndiaMalaysiaBangladesh
In The Last Decade
Jaykaran Charan
88 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Infectious Diseases 878
- Molecular Biology 680
- Public Health, Environmental and Occupational Health 551
- Epidemiology 542
- Surgery 439
Countries citing papers authored by Jaykaran Charan
This map shows the geographic impact of Jaykaran Charan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaykaran Charan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaykaran Charan more than expected).
Fields of papers citing papers by Jaykaran Charan
This network shows the impact of papers produced by Jaykaran Charan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaykaran Charan. The network helps show where Jaykaran Charan may publish in the future.
Co-authorship network of co-authors of Jaykaran Charan
This figure shows the co-authorship network connecting the top 25 collaborators of Jaykaran Charan. A scholar is included among the top collaborators of Jaykaran Charan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaykaran Charan. Jaykaran Charan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 27 | |
| 7 | 180 | |
| 8 | 3 | |
| 9 | 64 | |
| 10 | 53 | |
| 11 | Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database | 6 |
| 12 | 29 | |
| 13 | The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications | 1 |
| 14 | 9 | |
| 15 | 2 | |
| 16 | Antibiotics for the Treatment of Leptospirosis: Systematic Review and Meta-Analysis of Controlled Trials | 29 |
| 17 | How to calculate sample size in animal studies?breakdown → | 1319 |
| 18 | 6 | |
| 19 | BEWARE - STATISTICS MAY DECEIVE YOU | 2 |
| 20 | 13 |
About Jaykaran Charan
Jaykaran Charan is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Molecular Medicine, having authored 99 papers that have together received 5.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (18 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Pharmaceutical Economics and Policy (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (167 citations), Infectious Diseases (878 citations) and Geriatrics and Gerontology (116 citations). Jaykaran Charan has collaborated with scholars based in India, Malaysia and Bangladesh. Frequent co-authors include Tamoghna Biswas, N. D. Kantharia, Rimple Jeet Kaur, Deepak Saxena, Pankaj Bhardwaj, Jagdish Prasad Goyal, Siddhartha Dutta, Mainul Haque, Preeti Yadav and Surjit Singh. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.